Average Premiums for Health Care Coverage Stable in 2016
Family premium 3 percent higher in 2016 than 2015; no change in share of firms offering health benefits
Early Rx With Losartan Doesn’t Slow Kidney Disease Progression
Findings in American-Indians with type 2 diabetes and urine albumin/creatinine ratio <300 mg/g
Importance of Drug As Assessed by Doctor Not Tied to Adherence
About 20 percent of drugs considered important by physicians were not taken correctly by patients
Recommendations Developed for Cost-Effectiveness Analyses
Concept of reference case, set of standard practices that all analyses should follow is recommended
Value-Driven Outcomes Tool Can Cut Health Care Costs
Highest variability in costs identified for post-op infection and sepsis, lowest for organ transplant
Many Medicare Patients Non-Adherent to Antihypertensives
Antihypertensive medication regimens should be made as easy-to-follow as possible
New Anticancer Drugs Up Costs and Life Expectancy Considerably
Lifetime costs up $72,000, life expectancy up 13 months with new drug use in breast cancer
Advanced Glycation End Products Tied to Renal Function Loss
AGEs improve RFL prediction in American-Indians with type 2 diabetes
Liraglutide, Sitagliptin Have No Effect on Renal Hemodynamics
No change in effective renal plasma flow, other intrarenal hemodynamic measures
Limited Dialyzability for Oxycodone, Noroxycodone
Significant mean reduction in oxycodone, noroxycodone arterial concentrations
